HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%- hyaluronic acid sodium salt 0.5% / tazarotene 0.05% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%

Directions for use

e

Sincerus Florida, LLC. Adverse reactions

s

Active, inactive

x

NDC 72934-2093-2 HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%. Cream 30gm.

v

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05% 
hyaluronic acid sodium salt 0.5% / tazarotene 0.05% cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2093
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS) TAZAROTENE0.05 g  in 100 g
HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM0.5 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2093-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/10/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/10/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2093)

Revised: 5/2019
Document Id: 8879f8d5-e9c7-f749-e053-2a95a90a8af5
Set id: 8879f8d5-e9c6-f749-e053-2a95a90a8af5
Version: 1
Effective Time: 20190509
 
Sincerus Florida, LLC